Genetic control of suceptibility to Candida albicans in susceptible A/J and resistant C57BL/6J mice

Genes and Immunity

Volumn 6, Issue 8, 2005, Pages 672-682

  Tuite, A ^a   Elias, M ^b   Picard, S ^b   Mullick, A ^b   Gros, Philippe ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c Department of Biochemistry ^*  (Canada)

Author keywords

C. albicans; C5; Genetics; Infection

Indexed keywords

COMPLEMENT COMPONENT C5; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC REGULATION; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; KIDNEY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEGREGATION ANALYSIS; SURVIVAL TIME; A J MOUSE; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; C57BL MOUSE; CHI SQUARE DISTRIBUTION; CHROMOSOME; CHROMOSOME MAP; COMPARATIVE STUDY; CONGENIC STRAIN; DISEASE PREDISPOSITION; GENETIC LINKAGE; GENETIC MARKER; GENETICS; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY; SPECIES DIFFERENCE; SURVIVAL;

ANIMALIA; CANDIDA ALBICANS;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CANDIDA ALBICANS; CANDIDIASIS; CHI-SQUARE DISTRIBUTION; CHROMOSOME MAPPING; CHROMOSOMES; COMPLEMENT C5; DISEASE SUSCEPTIBILITY; GENETIC MARKERS; KIDNEY; LINKAGE (GENETICS); LOD SCORE; MICE; MICE, CONGENIC; MICE, INBRED A; MICE, INBRED C57BL; SPECIES SPECIFICITY; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 28544449559     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364254     Document Type: Article

References (47)

1. Mathews HL, Witek-Janusek L. Host defense against oral, esophageal, and gastrointestinal candidiasis. In: Calderone RA (ed). Candida and candidiasis. ASM Press: Washington, DC, 2002, pp 179-192.
2. Odds FC. Candida and candidosis 2nd edn. Bailliáere Tindall: London, 1988.
3. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3: 685-702.
4. Kullberg BJ, Filler SG. Candidemia. In: Calderone RA (ed). Candida and candidiasis. ASM Press: Washington, DC, 2002, pp 327-340.
5. Choi EH, Foster CB, Taylor JG et al. Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes. J Infect Dis 2003; 187: 1153-1156.
6. Lanza F. Clinical manifestation of myeloperoxidase deficiency. J Mol Med 1998; 76: 676-681.
7. Tuite A, Mullick A, Gros P. Genetic analysis of innate immunity in resistance to Candida albicans. Genes Immun 2004; 5: 576-587.
8. Mullick A, Elias M, Picard S et al. Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain. Infect Immun 2004; 72: 5868-5876.
9. Cockayne A, Odds FC. Interactions of Candida albicans yeast cells, germ tubes and hyphae with human polymorphonuclear leucocytes in vitro. J Gen Microbiol 1984; 130 (Part 3): 465-471.
10. Baccarini M, Vecchiarelli A, Cassone A, Bistoni F. Killing of yeast, germ-tube and mycelial forms of Candida albicans by murine effectors as measured by a radiolabel release microassay. J Gen Microbiol 1985; 131 (Part 3): 505-513.
11. Aratani Y, Kura F, Watanabe H et al. Critical role of myeloperoxidase and nicotinamide adenine dinucleotide phosphate-oxidase in high-burden systemic infection of mice with Candida albicans. J Infect Dis 2002; 185: 1833-1837.
12. Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F, Maeda N. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 1999; 67: 1828-1836.
13. Netea MG, Van Der Graaf CA, Vonk AG, Verschueren I, Van Der Meer JW, Kullberg BJ. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis 2002; 185: 1483-1489.
14. Villamon E, Gozalbo D, Roig P, O'Connor JE, Fradelizi D, Gil ML. Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect 2004; 6: 1-7.
15. Netea MG, Sutmuller R, Hermann C et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 2004; 172: 3712-3718.
16. Bellocchio S, Montagnoli C, Bozza S et al. The contribution of the toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004; 172: 3059-3069.
17. Romani L. Immunology of invasive candidiasis. In: Calderone RA (ed) Candida and candidiasis. ASM Press: Washington DC, 2002, pp 223-241.
18. Gelfand JA, Hurley DL, Fauci AS, Frank MM. Role of complement in host defense against experimental disseminated candidiasis. J Infect Dis 1978; 138: 9-16.
19. Ashman RB. A gene (Carg1) that regulates tissue resistance to Candida albicans maps to chromosome 14 of the mouse. Microb Pathogenesis 1998; 25: 333-335.
20. Ashman RB, Fulurija A, Papadimitriou JM. A second Candida albicans resistance gene (Carg2) regulates tissue damage, but not fungal clearance, in sub-lethal murine systemic infection. Microb Pathogenesis 1998; 25: 349-352.
21. Fortin A, Diez E, Rochefort D et al. Recombinant congenic strains derived from A/J and C57BL/6J: A tool for genetic dissection of complex traits. Genomics 2001; 74: 21-35.
22. Ashman RB. Candida albicans: Pathogenesis, immunity and host defence. Res Immunol 1998; 149: 281-288; discussion 494-496.
23. Balish E, Wagner RD, Vazquez-Torres A, Pierson C, Warner T. Candidiasis in interferon-gamma knockout (IFN-gamma-/-) mice. J Infect Dis 1998; 178: 478-487.
24. Lavigne LM, Schopf LR, Chung CL, Maylor R, Sypek JP. The role of recombinant murine IL-12 and IFN-gamma in the pathogenesis of a murine systemic Candida albicans infection. J Immunol 1998; 160: 284-292.
25. Netea MG, van Tits LJ, Curfs JH et al. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol 1999; 163: 1498-1505.
26. Romani L, Mencacci A, Cenci E et al. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 1996; 183: 1345-1355.
27. Blake JA, Richardson JE, Bult CJ, Kadin JA, Eppig JT. MGD: The mouse genome database. Nucleic Acids Res 2003; 31: 193-195.
28. Ashman RB, Fulurija A, Papadimitriou JM. Strain-dependent differences in host response to Candida albicans infection in mice are related to organ susceptibility and infectious load. Infect Immun 1996; 64: 1866-1869.
29. Ashman RB, Bolitho EM, Papadimitriou JM. Patterns of resistance to Candida albicans in inbred mouse strains. Immunol Cell Biol 1993; 71 (Part 3): 221-225.
30. Ashman RB, Papadimitriou JM, Fulurija A et al. Role of complement C5 and T lymphocytes in pathogenesis of disseminated and mucosal candidiasis in susceptible DBA/2 mice. Microb Pathogenesis 2003; 34: 103-113.
31. Wetsel RA, Fleischer DT, Haviland DL. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5′-exon. J Biol Chem 1990; 265: 2435-2440.
32. Ashman RB, Fulurija A, Papadimitriou JM. Evidence that two independent host genes influence the severity of tissue damage and susceptibility to acute pyelonephritis in murine systemic candidiasis. Microb Pathogenesis 1997; 22: 187-192.
33. D'Eustachio P, Kristensen T, Wetsel RA, Riblet R, Taylor BA, Tack BF. Chromosomal location of the genes encoding complement components C5 and factor H in the mouse. J Immunol 1986; 137: 3990-3995.
34. Cinader B, Dubiski S, Wardlaw AC. Distribution, inheritance, and properties of an antigen, Mub1, and its relation to hemolytic complement. J Exp Med 1964; 120: 897-924.
35. Janeway C, Travers P, Walport M, Shlomchik M. Immunobiology. 5: The Immune System in Health and Disease 5th edn. Garland Pub.: New York, 2001.
36. Kozel TR. Activation of the complement system by pathogenic fungi. Clin Microbiol Rev 1996; 9: 34-46.
37. Gerard C, Gerard NP. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu Rev Immunol 1994; 12: 775-808.
38. Blatteis CM, Li S, Li Z, Perlik V, Feleder C. Signaling the brain in systemic inflammation: The role of complement. Front Biosci 2004; 9: 915-931.
39. Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol 2004; 4: 133-142.
40. Papadimitriou JM, Ashman RB. The pathogenesis of acute systemic candidiasis in a susceptible inbred mouse strain. J Pathol 1986; 150: 257-265.
41. Ashman RB, Papadimitriou JM. Murine candidiasis. Pathogenesis and host responses in genetically distinct inbred mice. Immunol Cell Biol 1987; 65 (Part 2): 163-171.
42. Rifkind D, Frey JA. Sex difference in antibody response of CFW mice to Candida albicans. Infect Immun 1972; 5: 695-698.
43. Ashman RB, Kay PH, Lynch DM, Papadimitriou JM. Murine candidiasis: Sex differences in the severity of tissue lesions are not associated with levels of serum C3 and C5. Immunol Cell Biol 1991; 69 (Part 1): 7-10.
44. Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991; 4: 359-395.
45. Mitsos LM, Cardon LR, Fortin A et al. Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice. Genes Immun 2000; 1: 467-477.
46. Lander ES, Green P, Abrahamson J et al. MAPMAKER: An interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics 1987; 1: 174-181.
47. Manly KF, Olson JM. Overview of QTL mapping software and introduction to map manager QT. Mamm Genome 1999; 10: 327-334.